Table 3.
Parameter | Group C n = 30 |
Group N n = 30 |
Group M n = 30 |
F | P | C&N P1 |
C&M P2 |
N&M P3 |
---|---|---|---|---|---|---|---|---|
NPRS | 5.61±1.58 | 1.78±0.76 | 2.64±0.8 | 97.86 | 0.000 | <0.001 | <0.001 | <0.001 |
Effective analgesic time (min) | 185.5±17.45 | 263.7±16.3 | 224.2±18.6 | 150.19 | 0.000 | <0.001 | <0.001 | <0.001 |
Total ketorolac dose (mg) in first 24hours | 58.8±12.4 | 37.9±15.2 | 48.3±15.6 | 15.65 | 0.000 | <0.001 | 0.005 | 0.01 |
Total dose of pethidine (mg) in first 24 hours |
46.5±13.3 | 31.6±10.8 | 34.75±12.5 | 12.34 | 0.000 | <0.001 | 0.001 | 0.3 |
Notes: Data were expressed as mean±SD; group C, control group; group N, nalbuphine group; group M, midazolam group; min, minute; p1, group C versus group N; p2, group C versus group M; p3, group N versus group M; NPRS, Numeric Pain Rating Scale; p < 0.05 was significant and p <0.001 was highly significant. F-test (ANOVA), one way analysis of variance. Post hoc test was done to detect exactly which groups had a difference in means.